Ipratropium and Albuterol Solution

Ipratropium and albuterol solution is used to treat chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. The medication is a combination of two medications and is used when people with COPD need more than one medication to prevent airway spasms. Ipratropium and albuterol solution comes in a liquid form and is typically taken four times a day using a nebulizer.

 

What Is Ipratropium and Albuterol Solution?

Ipratropium and albuterol solution (DuoNeb®) is a prescription medication used to prevent airway spasms (also known as bronchospasms) caused by chronic obstructive pulmonary disease (COPD), including emphysema and chronic bronchitis. Ipratropium and albuterol solution contains two different medications: albuterol sulfate (Proair®, Proventil®, Ventolin®) and ipratropium bromide (Atrovent®).
 
Ipratropium and albuterol solution is approved for treating COPD in people who need more than one medication to prevent airway spasms. The medication is inhaled using a nebulizer (a device that changes liquid medications into fine droplets that are inhaled into the lungs).
 
(Click What Is Ipratropium and Albuterol Solution Used For? for more information, including possible off-label uses.)
 

Ipratropium and Albuterol Solution Side Effects

As with any medicine, side effects are possible with ipratropium and albuterol solution. However, not everyone who takes the drug will experience side effects. In fact, most people tolerate it quite well. If side effects do occur, in most cases, they are minor and either require no treatment or can easily be treated by you or your healthcare provider. Serious side effects are less common.
 
Common side effects of ipratropium and albuterol solution include but are not limited to:
 
  • Sore throat
  • Chest pain
  • Diarrhea
  • Bronchitis.
     
(Click Side Effects of Ipratropium and Albuterol Solution to learn more, including potentially serious side effects that you should report immediately to your healthcare provider.)
 
(Ipratropium and Albuterol Solution Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;